Auto logout in seconds.
Continue LogoutIn the United States, about 1 in 40 adults will be diagnosed with obsessive-compulsive disorder (OCD) during their lifetime, and roughly 1 in 100 children and teens live with the condition.1 A disorder characterized by intrusive thoughts and compulsive behaviors or rituals, OCD is also one of the most frequently misdiagnosed behavioral health disorders, often leading to patient distress, symptom escalation, and higher costs due to misguided treatment.2
Despite these challenges, OCD is highly treatable. Exposure and response prevention (ERP) therapy is a first-line treatment for OCD3,4,5 that works by gradually exposing patients to stimuli that evoke their obsessions, associated distress, and urges to do compulsi. The therapist guides patients to resist those behaviors, so both the distress and the urge to do the behaviors decrease over time. But patients can’t always access ERP-based therapy, whether due to a lack of transportation, time, or finances.4
To deliver consistent care, NOCD developed a digital ERP program that uses live video sessions, app-based tools, community forums, and therapist messaging between sessions to support patients with OCD. On average, most patients receive three weeks of twice-weekly video ERP sessions, six weeks of weekly check-ins and follow-up assessments.6
In partnership with NOCD, Optum Advisory analyzed the impact of OCD care on overall healthcare utilization and costs to better understand the opportunity for effectively treating OCD with . That study revealed that compared to other provider-led OCD solutions, NOCD’s ERP-based treatment saved $3,430 per member per year.7 Here are three takeaways from Optum Advisory’s findings on how NOCD’s virtual ERP therapy impacts patient outcomes, utilization patterns, and overall costs — plus strategies healthcare organizations can use to improve care and reduce spending.
The severity of a patient’s symptoms often determines the care setting for OCD. Patients with mild or moderate symptoms are typically treated in outpatient settings, while those with severe symptoms are more likely to be treated in intensive health settings like inpatient care.7 People with OCD are often misdiagnosed, leading to incorrect treatment.2
Because severe OCD drives higher utilization rates, it accounts for a disproportionate share of costs. In the Optum Advisory study, among health plan members with OCD, less than 9% were severe, yet this cohort drove higher annual per-member costs than mild or moderate OCD across all care settings. Comorbid conditions amplified this impact: For example, OCD-related depression and eating disorders drove the highest average costs annually per member at $13,339 and $85,335, respectively.7 Importantly, treatment of OCD with ERP therapy significantly improves depressive symptoms.6,8
These data suggest that health plans and health systems should prioritize helping patients with OCD get access to evidence-based ERP therapy. Effective outpatient treatment can help patients avoid the need for inpatient care — a dynamic that emphasizes the need for screening early, before symptoms worsen or become more resistant to treatment.6 Virtual ERP-based therapy could be key to getting those patients care quickly.7 For example, quick access to virtual ERP solutions like NOCD could prevent patients from progressing to severe OCD.6
Multidisciplinary care teams often provide a stepped approach to OCD care, so patients receive care that matches their needs.9 Care teams also consider other important factors such as each patient’s comorbidities and response to prior treatments. Once a patient is screened and diagnosed, rapid access channels within clinical pathways allow care teams to quickly refer patients with OCD to evidence-based therapy for help managing symptoms before inpatient care becomes necessary.7
Beyond guiding patients to the right OCD treatment, rapid access channels also enable screening and referrals for common comorbidities, especially for conditions that require medication management.
Integrating proven virtual ERP therapy like NOCD into team-based care pathways adds an accessible option for timely, targeted intervention. Because the therapy is delivered remotely, care teams can reach rural or underserved populations without the need for additional physical infrastructure.10
OCD is a chronic condition, and symptoms can fluctuate throughout a patient’s life. Effective treatment and supportive environments can help alleviate symptoms, while stress and major life changes often make symptoms worse.11
While patients with severe OCD drove the highest costs, more than 60% of health plan members in Optum Advisory’s study had moderate OCD.7
This finding underscores a critical opportunity: Intervention during earlier stage of OCD can significantly reduce clinical burden, utilization, and cost. First, better screening for OCD at the mild and moderate stages will help more patients get the treatment they need. Second, proven virtual ERP therapy methods like NOCD could be integral to that process, because they offer quick, accessible OCD treatment that can prevent patients from progressing to severe OCD.
Addressing moderate OCD early and leveraging multidisciplinary, team-based approaches like virtual ERP solutions can prevent costly inpatient utilization and improve outcomes. By prioritizing timely intervention for moderate cases and enhancing access to specialized care, health systems can more effectively manage OCD and its comorbidities, ultimately delivering better care while curbing overall spend.
1 About OCD. International OCD Foundation. Accessed November 4, 2025.
2 Stahnke B. A systematic review of misdiagnosis in those with obsessive-compulsive disorder. Journal of Affective Disorder Reports. September 17, 2021.
3 OCD Treatment Guide: Best Evidence-Based Therapies, Medications, and New Advances. International OCD Foundation. Accessed November 4, 2025.
4 Law C, Boisseau CL. Exposure and Response Prevention in the Treatment of Obsessive-Compulsive Disorder: Current Perspectives. Psychology Research and Behavior Management. December 24, 2019.
5 Mao L, et al. The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis. Frontiers. September 14, 2022.
6 Feusner JD, et al. Online Video Teletherapy Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention: Clinical Outcomes from a Retrospective Longitudinal Observational Study. Journal of Medical Internet Research. May 19, 2022.
7 NOCD Clinical and Cost Outcomes Study. Optum Advisory. October 15, 2025.
8 Feusner JD, et al. Effectiveness of Video Teletherapy in Treating Obsessive-Compulsive Disorder in Children and Adolescents With Exposure and Response Prevention: Retrospective Longitudinal Observational Study. J Med Internet Res. January 27, 2025.
9 Mareya S, et al. Exploring the Stepped Care Model in Delivering Primary Mental Health Services — A Scoping Review. International Journal of Mental Health Nursing. September 20, 2024.
10 Bello T. Why You Should Integrate Your Telehealth & ERP Systems. HomeCare. October 15, 2021.
11 Ferriera S, et al. Stress Influences the Effect of Obsessive-Compulsive Symptoms on Emotion Regulation. Frontiers. January 19, 2021.
NOCD is setting the standard for how complex mental and behavioral health conditions are identified and managed, with the goal of ending the mental health crisis — starting with OCD and related conditions. As the world’s leading provider of OCD treatment, NOCD helps people reclaim their lives through specialized virtual therapy covered by insurance for over 138 million Americans. Members work with primarily full-time licensed therapists trained in OCD and Exposure and Response Prevention (ERP) therapy, the most effective and evidence-based approach for treating OCD, while also receiving ongoing support and progress tracking through the NOCD app. Founded in 2015 by CEO Stephen Smith, whose personal experience with OCD inspired him to create the company, NOCD is redefining how evidence-based mental health care is delivered — accessible, affordable, and effective for all.
This report is sponsored by NOCD, an Advisory Board member organization. Representatives of NOCD helped select the topics and issues addressed. Advisory Board experts wrote the content, maintained final editorial approval, and conducted the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.
To learn more, view our editorial guidelines.
This report is sponsored by NOCD. Advisory Board experts conducted the research and maintained final editorial approval.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.